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Nondominant small follicles are a
promising source of mature oocytes
in modiﬁed natural cycle in vitro
fertilization and embryo transfer
Shokichi Teramoto, M.D.,a Hisao Osada, M.D., Ph.D.,a Yasunori Sato, Ph.D.,b and Makio Shozu, M.D., Ph.D.c
a Shimbashi Yume Clinic, Tokyo; b Clinical Research Center, Chiba University Hospital, Chiba; and c Department of
Reproductive Medicine, Chiba University Postgraduate School of Medicine, Chiba, JapanObjective: To determine whether oocyte retrieval from nondominant small follicles supplies mature oocytes and increases live births in
natural cycle IVF and embryo transfer (IVF-ET).
Design: Retrospective cohort study.
Setting: Private assisted reproductive technology practice.
Patient(s): Seven hundred seventy-one infertile women who underwent natural cycle IVF between 2011 and 2013.
Intervention(s): The LH surge was triggered via nasal buserelin when the dominant follicle reached 16–18 mm during nonstimulated
cycles, and as many oocytes as possible were retrieved from nondominant small follicles (a diameter of 3–10mm) after retrieval from the
large (dominant) follicle. The embryos were cryopreserved once they had yielded good-quality blastocysts and then transferred (one per
cycle) during subsequent cycles.
Main Outcome Measure(s): Number of mature oocytes (metaphase II) and resulting live births yielded via oocyte retrieval from the
initial cycle of treatment.
Result(s): Among 771 women, nondominant small follicle puncture yielded 902 metaphase II oocytes and 78 live births, whereas large
dominant follicle puncture yielded 466 metaphase II oocytes and 90 live births. Successes in oocyte retrieval and live births resulting
from small follicle puncture were positively correlated with ovarian reserve but did not depend on the outcomes of the dominant follicle
puncture.
Conclusion(s): Nondominant small follicles are a promising supplementary source of mature oocytes for natural cycle IVF. (Fertil Ster-
il 2016;106:113–8. Copyright2016 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Med-
icine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).)
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Several modiﬁcations have been
reported to enhance the pregnancy
rate with natural cycle IVF. One such
method is the combination of IVF and
in vitro maturation (IVM), in which
immature oocytes are deliberately
collected from small follicles before
the dominant/nondominant follicle se-
lection. These oocytes are matured
in vitro before fertilization and eventu-
ally used for ET (2). This combination
(natural cycle IVM/IVF) enhances the
pregnancy rate for natural cycle IVF113
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONby 36%, compared with that for natural cycle IVF using only
dominant-follicle oocytes (2, 3). The rationale for IVM/IVF is
the retrieval of immature oocytes from nonselected small
follicles before the oocytes have lost their developmental
competency (4, 5). In this context, the optimal timing for
collection has been empirically determined to be when the
dominant follicle has reached a diameter of 12–14 mm,
which is at approximately day 10 of the menstrual cycle (5, 6).
Another possible method to enhance the pregnancy rate
for natural cycle IVF is the use of oocytes from nondominant
(nonselected) small follicles that appear alongside a dominant
(selected) large follicle. Mature oocytes are retrieved via unin-
tentional or intentional puncture of nondominant small folli-
cles at the time of scheduled mid-cycle oocyte retrieval from
dominant follicles in the setting of natural cycle IVF. This
means that some nondominant small follicles (suspected at-
retic follicles) harbor mature oocytes. However, it has been
unclear how often these nondominant small follicles harbor
mature oocytes that are competent for live birth.
Herein we report a study in which we retrieved as many
oocytes as possible via intentional puncture of small follicles
and determined whether systematic puncture of nondominant
small follicles enhanced the live birth rate of natural cycle
IVF.FIGURE 1
Flowchart for patient selection and summary of outcomes. F ¼ follicle.
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114MATERIALS AND METHODS
Study Population
This retrospective cohort study included patients who visited
the Shimbashi Yume Clinic for the ﬁrst time between
February 1, 2011, and September 30, 2013. Natural cycle
IVF was offered to all the patients for whom IVF was the indi-
cated mode of treatment. The study design was reviewed and
approved by the institutional review board of our clinic
(SYC2011-1). Patients who agreed to this form of treatment
and gave their informed consent were included in this study.
Additional inclusion criteria were patients who were 30–
40 years old and whose most recent menstrual cycle was in
the past 24–45 days. Women with ovaries that were difﬁcult
to visualize and puncture under ultrasound guidance (e.g.,
owing to uterine ﬁbroids, endometriotic cysts, and/or exten-
sive pelvic adhesions) were excluded. Although couples with
azoospermia were excluded, couples with oligozoospermia
were included in this study.
On the basis of these criteria, 1,291 patients started natu-
ral cycle IVF during the study period (approximately 90% of
all new patients) (Fig. 1). Patients who did not exhibit follic-
ular growth (R11 mm) by day 31 of the cycle were excluded
from the analysis. Patients who exhibited acceleratedVOL. 106 NO. 1 / JULY 2016
Fertility and Sterility®follicular growth (R16 mm before day 10 of the cycle) and/or
premature elevation of LH levels (>3 the day-3 basal level
and demonstrating a tendency to increase further) were also
excluded. Thus, 809 patients received buserelin to trigger
the LH surge. Patients whose dominant follicle had ruptured
or who did not have any small follicles (3–10 mm) on the
morning of the scheduled oocyte retrieval were also excluded.
As a result, 771 patients who had at least one large follicle and
one small follicle were considered eligible for the analysis.Causes and Duration of Infertility
The major causes of infertility were male factors (48% of
cases), unexplained infertility (38%), tubal factors (11%),
and male factors combined with tubal factors (3%). The
mean duration  SD (range) of infertility was 4.5  3.2 years
(0.1–16.0 years). A total of 37.1% of the patients had under-
gone IVF-ET treatment at other institutions. All patients
had a history of infertility treatment.Follicular Monitoring and LH Triggering
Follicular monitoring via ultrasonography and hormonal
measurements were started on day 3, and both were repeated
on day 10 and every day or every other day thereafter. Once
the dominant follicle reached a diameter of 16–18 mm and
E2 levels of R190 pg/mL, buserelin acetate (300 mg/mL)
was administered nasally, and oocyte retrieval was performed
32–36 hours later by one of the authors (S.T.).Oocyte Retrieval
The follicles were measured and video-traced immediately
before the oocyte retrieval. The oocytes were aspirated using
a 23-gauge needle. For each retrieval, a dominant follicle
was aspirated, and then as many nondominant follicles
(diameter ofR3 mm) as possible were sequentially aspirated
(Representative Videos are supplied as a supplement, avail-
able online). Follicles were segregated into two groups: a large
follicle group (R11 mm, deﬁned as the dominant follicles)
and a small follicle group (3–10 mm, deﬁned as nondominant
follicles) because the intermediate-size (11–15 mm) follicles
were closer to the larger follicles (R16 mm) compared with
the smaller follicles (%10 mm) in terms of oocyte maturity
and competency (Supplemental Tables 1 and 2, available on-
line). On average, 12.8 small follicles per patient were punc-
tured, which yielded 5.3 oocytes per patient. For
nondominant follicles, multiple aspirates were collected into
a single syringe using the minimal number of ovarian punc-
tures. Follicle ﬂushing was not performed.IVF-ET
Every oocytewas released from the cumulus cells, and itsmatu-
ration status was determined via phase-contrast microscopy
within 3 hours of the retrieval. Every oocyte was then cultured
separately in a 20-mL droplet of human tubalﬂuidmedium (Ki-
tazato BioPharma) that contained 0.4% human serum albumin.
Mature oocytes were inseminated via IVF or intracytoplasmic
sperm injection, and fertilization was conﬁrmed on day 1, onVOL. 106 NO. 1 / JULY 2016the basis of the identiﬁcation of pronuclei. Degenerated or
damaged oocytes were excluded from the analysis.
Fertilized embryos were cultured in Quinn's Advantage
Protein Plus Cleavage Medium (Sage) for days 1–2, and in
Quinn's Advantage Protein Plus Blastocyst Medium (Sage)
thereafter. Once blastocysts met the criteria for good-quality
blastocysts, they were all cryopreserved using vitriﬁcation.
The criteria for good-quality blastocysts were as follows: a
R180-mm diameter withR12 trophectoderm cells observed
in the largest section of the blastocyst on day 5 or 6 of culture,
or aR200-mmdiameter withR18 trophectoderm cells on day
7. Blastocysts that did not fulﬁll any of these criteria by the end
of day 7 were not used for blastocyst transfer (BT).
All BTs were performed 4.5–5 days after spontaneous
ovulation at the natural ovulation cycle that followed the
initial oocyte retrieval cycle. If the endometrial thickness
was%6mm, BTwas canceled for that cycle and thenwas per-
formed during the next cycle with estrogen and progestin
supplementation. All ETs were single BTs and were guided
via transvaginal ultrasonography. If the patient had two or
more frozen blastocysts, the blastocyst that was frozen earlier
was selected for the BT. All the blastocysts were transferred
and included in the analysis, with 10 unavoidable exceptions
(detailed in the Supplemental Text).Vitriﬁcation/Warming
Vitriﬁcation and warming of the blastocysts were conducted
using the Cryptop device (Kitazato), according to the manu-
facturer's instructions (7).Outcomes
The primary outcome was deﬁned as a live birth at
R22 weeks' gestation. Clinical and ongoing pregnancies
were deﬁned as the detection of a gestational sac by 6 weeks'
gestation and the detection of a fetal heartbeat at >7 weeks’
gestation, respectively. Outcomes analyses were performed at
2 years after the last patient was enrolled, and all of the good-
quality blastocysts except one were used for treatment (the
exception is detailed in the Supplemental Text).Statistical Analysis
All analyses were performed using the intention-to-treat
principle. For patient characteristics, summary statistics
were constructed using frequencies and proportions for cate-
gorical data, and means, SDs, and ranges for continuous vari-
ables. Patient characteristics were compared using the c2 test
or Fisher's exact test (when one or more of the expected fre-
quencies were less than 5) for categorical outcomes, and using
the t test or the Wilcoxon rank sum test for continuous vari-
ables, as appropriate.
To evaluate the factors affectingoocyte recovery, themulti-
variate logistic regression model was applied to adjust for
possible confounding factors.P values of< .05were considered
statistically signiﬁcant. All statistical analyses were performed
using JMP software (version 12.0; SAS Institute).115
TABLE 2
Per-oocyte outcomes for MII oocytes.
Parameter
Nondominant
follicle
(% MII oocytes)
Dominant
follicle
(% MII oocytes)
No. of MII oocytes retrieved 902 (100.0) 466 (100.0)
No. of fertilized oocytes 772 (85.6) 400 (85.8)
No. of blastocysts 199 (22.1) 245 (52.6)
No. of good-quality blastocysts 165 (18.3) 209 (44.8)
No. of blastocyst transfers 161a (18.0) 203b (43.6)
No. of clinical pregnancies 95 (10.5) 115 (24.7)
No. of ongoing pregnancies 84 (9.3) 106 (22.7)
No. of live births 78 (8.6) 90c (19.3)
a Three good-quality blastocysts were discarded owing to damage during thawing.
b Six good-quality blastocysts were discarded without transfer owing to damage during
thawing (n ¼ 3) or withdrawal of the patient's consent for IVF-ET (n ¼ 3). One good-
quality blastocyst remains in storage for future use.
c Includes one twin (monozygotic-diamniotic) pregnancy, which was counted as one live
birth. Thus, a total of 91 babies were born via the initial oocyte retrieval.
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Nondominant Follicles Yield Mature Oocytes and
Live Births
From the 771 patients, 498 oocytes and 3,557 oocytes
were retrieved from dominant follicles and nondominant
follicles, respectively (Table 1). More than 25% of the
nondominant follicle–derived oocytes had matured (meta-
phase II, MII), and 85.6% of these oocytes were fertilized,
which yielded 165 good-quality blastocysts and 78 live
births (Table 2). The number of live births was nearly
comparable to that achieved via dominant follicle punc-
ture (n ¼ 90).
The overall outcomes are summarized in Figure 1. After
771 retrievals from the 771 patients, 90 patients achieved
live births via dominant follicle–derived blastocysts, and
another 75 patients achieved live births via nondominant
follicle–derived blastocysts. Two of the 90 patients who
had dominant follicle–derived live births also had a second
live birth via the use of frozen nondominant follicle–
derived blastocysts, and 1 of the 75 patients with nondom-
inant follicle–derived live births had a second live birth via
a cryopreserved nondominant follicle–derived blastocyst
(Fig. 1).Nondominant Follicle Puncture Yields Live Births
in Patients with No Oocyte from Dominant
Follicles
To clarify the utility of nondominant small follicle puncture,
patients were stratiﬁed according to the oocyte-retrieval re-
sults (Table 3). Among patients from whom oocytes could
not be obtained from dominant follicles (n ¼ 298), nondom-
inant follicle puncture provided one or more oocyte(s) in 261
patients (87.6%) and one or more live birth(s) in 38 patients
(12.8%). In comparison, among patients from whom oocytes
were obtained from dominant follicles (n ¼ 473), nondomi-
nant follicle puncture provided one or more oocyte(s) in 414TABLE 1
Oocytes from 771 patients via oocyte retrieval that was conducted at
the initial treatment cycle.
Parameter
Derived from
nondominant
follicles
Derived from
dominant
follicles
P
value
No. of patients with at least
one oocyte retrieved
675 473 < .0001a
Total no. of oocytes retrieved 3,557 498
Maturation status of the
viable oocytes at
retrievalb
< .0001c
MII, n (%) 902 (25.4) 466 (93.6)
MI, n (%) 322 (9.1) 21 (4.2)
GV, n (%) 2,333 (65.6) 11 (2.2)
Note:GV¼ germinal vesicles; MI¼ immature metaphase I oocytes, MII¼mature metaphase
II oocytes.
a Chi-squared test vs. total number of patients (n ¼ 771).
b Oocytes that were degenerated or damaged were not included (554 oocytes from
nondominant follicles and 151 oocytes from dominant follicles).
c Chi-squared test vs. total number of oocytes retrieved.
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116patients (87.5%) and one or more live birth(s) in 37 patients
(8.9%). Thus, nondominant follicle puncture was beneﬁcial
for women whose dominant large follicles did or did not yield
oocytes.Oocytes from Nondominant Follicles Reﬂect
Ovarian Reserve
To characterize patients whose oocytes were derived from
nondominant follicles, logistic regression analysis was per-
formed with adjustment for patient age, FSH levels on day
3, antim€ullerian hormone (AMH) levels on day 3, duration
from day 1 of the cycle to LH triggering, LH levels at trig-
gering, and E2 levels at triggering (Supplemental Table 3).
The results of the univariate and multivariate logistic regres-
sion analyses were essentially the same. Both FSH (adjusted
odds ratio 1.06 [95% conﬁdence interval 1.01–1.12];
P¼ .028) and AMH levels (adjusted odds ratio 0.96 [0.92–
0.99]; P¼ .002) were independent prognostic factors of oocyte
gain from nondominant follicles, but neither were prognostic
factors for oocyte gain from dominant follicles. This suggests
that oocyte gain from nondominant follicles is a reﬂection of
ovarian reserve.Nondominant Follicle–derived Blastocysts are
Competent
The developmental potential of matured oocytes was
compared between the dominant follicles and nondominant
follicles (Supplemental Fig. 1). For both dominant and
nondominant follicle-derived embryos, the greatest reduction
in the number of embryos occurred at blastocyst formation,
and the next largest reduction occurred at fertilization
(Supplemental Fig. 1A). Once the embryos developed into
good-quality blastocysts, the subsequent pregnancy rates
were not different between the dominant follicle–
derived and nondominant follicle–derived blastocysts
(Supplemental Fig. 1B).VOL. 106 NO. 1 / JULY 2016
TABLE 3
Stratiﬁed analysis regarding the utility of nondominant follicle puncture.
Parameter
No oocyte gained from dominant follicle (n[ 298) Oocyte(s) gained from dominant follicle (n[ 473)
No oocyte gained
from nondominant
follicle (n[ 37)
Oocyte(s) gained
from nondominant
follicle (n[ 261) P
No oocyte gained
from nondominant
follicle (n[ 59)
Oocyte(s) gained
from nondominant
follicle (n[ 414) P
Patient age (y) 37.1  2.3 [30–40] 36.6  2.7 [30–40] .3538 37.0  2.4 [30–40] 36.4  2.7 [30–40]. .1074
No. of follicles punctured per
patient
4.8  3.0 [2–16] 13.6  9.1 [1–56] < .0001 5.1  2.9 [2–14] 14.2  9.9 [2–53] < .0001
No. of oocytes retrieved per
patient
0.0  0.0 [0] 4.9  4.2 [1–23] < .0001 1.0  0.0 [1.0] 6.6  5.5 [2–41] < .001
No. of patients withR1
blastocyst transfer
(% within group)
0 (0.0) 65 (24.9) < .0001 22 (37.3) 230 (55.6) < .0004
No. of patients who achieved
R1 live birth (% within
group)
0 (0.0) 38 (14.6) < .0001 7 (11.2) 120 (30.0) .0007
Via nondominant follicle–
derived oocyte
0 38 0 37
Via dominant follicle–
derived oocyte
0 0 7 83
Note: Data are presented as mean  SD and [range] or the number of patients.
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Fertility and Sterility®DISCUSSION
Our study demonstrates that nondominant follicle puncture
yielded a signiﬁcant number of MII oocytes, which nearly
doubled the number of both good-quality blastocysts and
live births in a modiﬁed natural cycle IVF setting.
Nondominant follicle puncture resulted in live births in
>10% of the patients whose dominant follicle did not yield
oocytes. Therefore, nondominant follicle puncture can
serve as a supplementary source of oocytes to dominant
follicle IVF-ET.
To our knowledge, this is the ﬁrst report that has revealed
the clinical utility of nondominant follicle puncture in the
setting of nonstimulated and non-IVM IVF. In contrast,
mature oocytes are often recovered from small follicles during
COHS cycles. This is probably a different phenomenon from
what is observed during a nonstimulated cycle. It may be
that ‘‘small follicles’’ are rescued and start growing under
the inﬂuence of exogenous gonadotropins, and their harbored
oocytes start maturing.
In humans, follicle selection occurs during days 1–5 of
the cycle (8). The selected follicle continues to grow in size,
and the enclosed oocyte completes its development by the
time of the mid-cycle ovulation, whereas the non-selected
follicles cease to grow and undergo atresia (6). In these atretic
follicles, bioactive substances, such as steroids and growth
factors, cause irreversible changes in the granulose cells,
including apoptosis and luteinization. This decisive transition
in the follicular environment also induces a detrimental effect
on the oocyte's competency as the transition advances (9–11).
Therefore, it is generally accepted that the oocytes in non-
selected follicles lose their competency by the mid-cycle
ovulation (12).
Nevertheless, it has been noted that oocytes from nonse-
lected (atretic) follicles may undergo the ﬁnal capacitatingVOL. 106 NO. 1 / JULY 2016step and mature, because the atretic process of the early stage
is similar to that which occurs during the ﬁnal stage of the
dominant follicle (10,13–15). In swine, most oocytes in
atretic follicles are not degenerated, and 20% of them are in
the MII stage (16, 17). Our results indicated that, despite the
detrimental changes in the granulosa cells, some, but not
many, of these nonselected follicles matured, and the
enclosed oocytes were competent for live birth, at least until
the time of mid-cycle ovulation. This survival time of almost
1 week after the natural selection is longer than has ever been
estimated (10).
To gain a better understanding of the follicle selection
process, it would be interesting to determine whether
competent oocytes reside in the ‘‘small follicles’’ of women
with normal cycles. However, there are several limitations
of this study that need to be considered before any extrap-
olation from our ﬁndings is made to the physiology of
normal women. Although no medication was used to stim-
ulate follicular growth, buserelin was used to trigger the
LH surge, which means that the treatment cycle was actu-
ally a modiﬁed natural cycle rather than a true natural cy-
cle. Thus, the hormonal milieu that is caused by the
buserelin may have modiﬁed the oocyte's development
and resulted in oocyte maturation. Furthermore, our ob-
servations were only among infertile women, whose follic-
ular development may not be the same as that of normally
fertile women. Given these facts, further investigation is
necessary before extrapolating our ﬁndings to women's
normal physiology.
In summary, this study demonstrates that nondominant
small follicles are a promising supplementary source of
in vivo–matured oocytes and that their use increases the
live birth rate in natural cycle IVF. It also demonstrates that
the blastocysts from nondominant follicles are as competent117
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONas those from dominant follicles in terms of pregnancy. How-
ever, the health of the resulting infants must be monitored
with long-term follow-up.
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